Previous Close | 17.70 |
Open | 17.70 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 17.70 - 17.70 |
52 Week Range | 13.72 - 22.46 |
Volume | |
Avg. Volume | 1 |
Market Cap | 31.876B |
Beta (5Y Monthly) | 0.67 |
PE Ratio (TTM) | 27.23 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.19 (1.08%) |
Ex-Dividend Date | May 08, 2024 |
1y Target Est | N/A |
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.